Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
11/1998
11/19/1998CA2290756A1 Random peptides that bind to gastro-intestinal tract (git) transport receptors and related methods
11/19/1998CA2290443A1 Peptide parathyroid hormone analogs
11/19/1998CA2289960A1 Peptides having a cyclic structure and restoring the activities of p53 protein to mutant p53 protein
11/18/1998EP0877809A1 TOXOPLASMA GONDII ANTIGEN Tg20
11/18/1998EP0877807A1 Biologically active and particularly peptide molecules having a potentiating effect on growth hormone biological activity
11/18/1998EP0877629A2 Lipophilic peptides for macromolecule delivery
11/18/1998EP0877620A1 Peptides for altering osteoblast adhesion
11/18/1998EP0673254A4 6-position modified decapeptide lhrh antagonists.
11/17/1998US5837807 Dipeptides and cyclic peptide derivatives of amino tetrahydronaphthalenecarboxylic acid and helical domains
11/17/1998US5837685 Peptides from Pseudomonas syringae possessing broad-spectrum antibiotic activity
11/17/1998US5837684 Peptides
11/17/1998US5837674 Administering orally or by injection; oligopeptides
11/17/1998US5837533 Complexes comprising a nucleic acid bound to a cationic polyamine having an endosome disruption agent
11/17/1998US5837268 Immunogens; genetic engineering; noncytotoxic; antitumor agents for breast cancer
11/17/1998US5837248 Peptide capable of inducing immune response to human gastric cancer and agent for preventing or treating human gastric cancer, containing the peptide
11/12/1998WO1998050582A1 COMPLEX FORMATION BETWEEN dsDNA AND OLIGOMER OF HETEROCYCLES
11/12/1998WO1998050579A1 Fluorogenic protease substrates based on dye-dimerization
11/12/1998WO1998050573A1 Isolated melanin-like substance and method for producing the same
11/12/1998WO1998050563A1 Methods of production of an amidated peptide through the use of a fusion protein
11/12/1998WO1998050527A1 Method for generating activated t-cells and antigen-pulsed antigen-presenting cells
11/12/1998WO1998050422A1 A novel strain of bacillus for controlling plant diseases and corn rootworm
11/12/1998WO1998050058A1 Complex formation between dsdna and oligomer of heterocycles
11/12/1998WO1998050057A2 Agent for enhancing the heart force
11/12/1998WO1998032457A3 Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation
11/12/1998CA2702750A1 A novel strain of bacillus for controlling plant diseases and corn rootworm
11/12/1998CA2299455A1 Complex formation between dsdna and oligomer of heterocycles
11/12/1998CA2289742A1 Method for generating activated t-cells and antigen-pulsed antigen-presenting cells
11/12/1998CA2288806A1 Complex formation between dsdna and oligomer of heterocycles
11/12/1998CA2287204A1 Methods of production of an amidated peptide through the use of a fusion protein
11/11/1998EP0876611A1 Molecules that home to a selected organ or tissue in vivo and methods of identifying same
11/11/1998EP0876610A1 A method and use of polypeptide in sperm-egg binding to enhance or decrease fertility
11/11/1998EP0876507A2 MANIPULATION AND DETECTION OF PROTEIN PHOSPHATASE 2C - PP2C$g(a) - EXPRESSION IN TUMOR CELLS FOR CANCER THERAPY, PREVENTION AND DETECTION
11/11/1998EP0876489A2 Nucleic acids encoding polypeptides having absidia lipase activity
11/11/1998EP0876401A2 Methods and compositions for producing morphogen analogs
11/11/1998EP0876398A1 Induction of immune response against desired determinants
11/11/1998EP0876397A1 Tumor rejection antigens presented by hla-b44 molecules, and uses thereof
11/11/1998EP0876396A1 MIMOTOPES AND ANTI-MIMOTOPES OF HUMAN PLATELET GLYCOPROTEIN Ib/IX
11/11/1998EP0876337A2 New lh-rh antagonists with improved effectiveness
11/11/1998CN1040648C Process for preparing 1-deamino-8-D-arginine vasopressin
11/10/1998US5835382 Identification using a programmed computer: input three-dimensional coordinates of a subset of atoms in a peptide which is co-crystallized with a portion of erythropoietin receptor, computer screens database for similar structures
11/10/1998US5834433 Compounds and pharmaceutical uses of peptides of bombesin and GRP
11/10/1998US5834431 Oligopeptide as bradykinin antagonist, antiinflammatory agent; highly potent, stability; selective b1 receptor antagonists
11/10/1998US5834430 Potentiation of antibiotics
11/10/1998US5834266 Regulated apoptosis
11/10/1998US5834234 Nucleotide sequence coding; diagnosis of degenerative disorders
11/10/1998US5834221 Contacting body fluid sample with immunological binding partner specific for 3-hydroxypyridinium crosslinked peptide derived from carboxy-terminal telopeptide domain of type i collagen
11/10/1998US5834029 Nerve guidance channel containing bioartificial three-dimensional hydrogel extracellular matrix derivatized with cell adhesive peptide fragment
11/10/1998US5833990 Anti-inflammatory, tolerogenic and immunoinhibiting properties of carbohydrate binding peptides
11/10/1998US5833985 Bispecific molecules for use in inducing antibody dependent effector cell-mediated cytotoxicity
11/10/1998US5833943 Minimum recognition unit of a pem mucin tandem repeat specific monoclonal antibody
11/10/1998US5833942 Cyclic peptide derivatives of somatostatin; radiodiagnosis, therapy
11/10/1998CA2050786C An antimicrobial peptide and an antimicrobial composition
11/05/1998WO1998049561A1 Inhibitors of nuclear protein/nuclear receptor interaction
11/05/1998WO1998049556A1 Antibody recognizing collagen fragments
11/05/1998WO1998049285A1 Polypeptide capable of reacting with antibodies of patients suffering from multiple sclerosis and uses
11/05/1998WO1998049278A1 INHIBITORS OF CELLULOLYTIC, XYLANOLYTIC AND β-GLUCANOLYTIC ENZYMES
11/05/1998WO1998049197A1 Oligopeptidic inhibitors of elastases and methods of preparation thereof
11/05/1998WO1998049193A1 Novel cyclosporin derivatives, preparation and pharmaceutical compositions containing same
11/05/1998WO1998049192A1 SYNTHETIC PEPTIDE CONSTRUCTS FOR THE DIAGNOSIS AND TREATMENT OF PERIODONTITIS ASSOCIATED WITH $i(PORPHYROMONAS GINGIVALIS)
11/05/1998WO1998049189A1 (3r)-3-amino-4-carboxybutyraldehyde derivatives inhibiting the release of interleukin-1/beta
11/05/1998WO1998049142A1 Dna-binding pyrrole and imidazole polyamide derivatives
11/05/1998WO1998048848A1 Method for the preparation of facial metal tricarbonyl compounds and their use in the labelling of biologically active substrates
11/05/1998WO1998032469A3 Polymers
11/05/1998DE19720162A1 Mittel zur Steigerung der Herzkraft Means of increasing the myocardial contractile force
11/05/1998CA2815903A1 Synthetic peptide constructs for the diagnosis and treatment of periodontitis associated with porphyromonas gingivalis
11/05/1998CA2720332A1 Synthetic peptide constructs for the diagnosis and treatment of periodontitis associated with porphyromonas gingivalis
11/05/1998CA2288337A1 Polypeptide capable of reacting with antibodies of patients suffering from multiple sclerosis and uses
11/05/1998CA2288332A1 (3r)-3-amino-4-carboxybutyraldehyde derivatives inhibiting the release of interleukin-1/beta
11/04/1998EP0874639A1 Peptide inhibitors of a phosphotyrosine-binding domain containing protein
11/04/1998EP0874624A2 Hyaluronic acid receptors binding agents and the use thereof
11/04/1998EP0598034B1 Production of peptide amides
11/04/1998EP0486622B1 Direct radiolabeling of antibodies and other proteins with technetium or rhenium
11/04/1998CN1040541C Preparation of polypeptide compound
11/03/1998US5831016 Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes
11/03/1998US5831014 PNA combinatorial libraries and improved methods of synthesis
11/03/1998US5831005 Synthesis of N-substituted oligomers
11/03/1998US5831003 Peptides which bind to prothrombin and thrombin
11/03/1998US5831002 Hybrid polypeptide
11/03/1998US5831000 Hybrid calcitonin
11/03/1998US5830999 Carboxylic ligands, hexamers
11/03/1998US5830998 Allosteric modulators of the NMDA receptor and their use in the treatment of CNS disorders and enhancement of CNS function
11/03/1998US5830996 Cyclic peptide antitumor agent from an ascidian
11/03/1998US5830995 Fanphiregulins: a family of heparin-binding epithelial cell growth factors
11/03/1998US5830994 Peptide derivatives of alpha-MSH and their application
11/03/1998US5830863 Naturally occurring neurokinin a with modified amide bond connecting the two amino acids on the carboxy terminal
11/03/1998US5830858 Neurotrophic factor
11/03/1998US5830856 Radiolabeled compounds for thrombus imaging
11/03/1998US5830855 Lipodepsipeptides as antifungal and fungicidal agents
11/03/1998US5830755 T-cell receptors and their use in therapeutic and diagnostic methods
11/03/1998US5830753 Isolated nucleic acid molecules coding for tumor rejection antigen precursor dage and uses thereof.
11/03/1998US5830667 Human P450 IID6 cytochrome-derived peptide fragments, anti-peptide fragment antibodies, applications thereof in the diagnosis of autoimmune hepatitis
11/03/1998US5830641 Nucleotide sequence used as hybrid probe
11/03/1998US5830637 Solid phase support, separate zone functions
11/03/1998US5830634 Aids diagnosis, screening blood doners
11/03/1998US5830504 Cooperative combinations of ligands contained within a matrix
11/03/1998US5830462 Regulated transcription of targeted genes and other biological events
10/1998
10/29/1998WO1998047524A1 Gastrin receptor-avid peptide conjugates
10/29/1998WO1998047522A1 Bradykinin analogs as selective inhibitors of cell activation
10/29/1998WO1998047489A1 Sustained-release compositions and method for preparing same
10/29/1998CA2288027A1 Bradykinin analogs as selective inhibitors of cell activation
1 ... 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 ... 423